{"id":36500,"date":"2021-08-02T17:06:00","date_gmt":"2021-08-02T15:06:00","guid":{"rendered":"https:\/\/www.ipsen.com\/?post_type=press_release&p=36500"},"modified":"2024-07-23T12:18:29","modified_gmt":"2024-07-23T10:18:29","slug":"ipsen-and-exicure-enter-into-exclusive-collaboration-targeting-rare-neurodegenerative-disorders-2","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-exicure-enter-into-exclusive-collaboration-targeting-rare-neurodegenerative-disorders-2\/","title":{"rendered":"Ipsen and Exicure enter into exclusive collaboration targeting rare neurodegenerative disorders"},"content":{"rendered":"